Univariate analysis of factors potentially associated with low bone mineral density in patients with rheumatoid arthritis treated with biologics. (DOCX 14 kb
Spearmanâs rank correlation coefficients (r s) between calprotectin/conventional inflammatory mark...
Rates of adverse events (trimmed population) in patients receiving rituximab or anti-TNF agents. (DO...
Observer agreement, BML and synovitis grading, Bland-Altman analyses. (DOCX 12 kb
Baseline characteristics of each latent class (including data from Table 4). (DOCX 18 kb
Clinical and biological characteristics of rheumatoid arthritis (RA) patients treated with adalimuma...
Table S1. All univarately tested variables in the hip and knee cohort.á (DOCX 23 kb
Table S1. Baseline characteristics, subset with inflammatory biomarkers. Table S2. Baseline predicto...
Adjusted coefficients of determination (R 2 ) and standardized beta coefficients (β) of the base mo...
Incidence rates (95 % CI) of severe adverse events among RA patients; subgroup analysis for more eld...
Table S1 Subject characteristics of those included and those not included in the analysis. (DOCX 18 ...
Table S1. A comparison of the characteristics and outcomes of patients with and without osteoporosis...
Figure S1. Changes in bone marrow reticulin fibrosis, collagen deposition, and osteosclerosis in ind...
Associations between different grades of bone marrow lesions and knee symptoms. Figure S1. Associati...
Table S1. Search strategy. Table S2. Characteristics of included studies. (DOCX 61 kb
Coefficients (r) with 95% confidence intervals for correlation between all model variables for inclu...
Spearmanâs rank correlation coefficients (r s) between calprotectin/conventional inflammatory mark...
Rates of adverse events (trimmed population) in patients receiving rituximab or anti-TNF agents. (DO...
Observer agreement, BML and synovitis grading, Bland-Altman analyses. (DOCX 12 kb
Baseline characteristics of each latent class (including data from Table 4). (DOCX 18 kb
Clinical and biological characteristics of rheumatoid arthritis (RA) patients treated with adalimuma...
Table S1. All univarately tested variables in the hip and knee cohort.á (DOCX 23 kb
Table S1. Baseline characteristics, subset with inflammatory biomarkers. Table S2. Baseline predicto...
Adjusted coefficients of determination (R 2 ) and standardized beta coefficients (β) of the base mo...
Incidence rates (95 % CI) of severe adverse events among RA patients; subgroup analysis for more eld...
Table S1 Subject characteristics of those included and those not included in the analysis. (DOCX 18 ...
Table S1. A comparison of the characteristics and outcomes of patients with and without osteoporosis...
Figure S1. Changes in bone marrow reticulin fibrosis, collagen deposition, and osteosclerosis in ind...
Associations between different grades of bone marrow lesions and knee symptoms. Figure S1. Associati...
Table S1. Search strategy. Table S2. Characteristics of included studies. (DOCX 61 kb
Coefficients (r) with 95% confidence intervals for correlation between all model variables for inclu...
Spearmanâs rank correlation coefficients (r s) between calprotectin/conventional inflammatory mark...
Rates of adverse events (trimmed population) in patients receiving rituximab or anti-TNF agents. (DO...
Observer agreement, BML and synovitis grading, Bland-Altman analyses. (DOCX 12 kb